Dear colleagues!
You hold in your hands a new magazine - "Endocrinology: news, opinion, education is a peer - reviewed scientific-practical magazine for continuing medical education of doctors, created with the participation of the country's leading experts in the field of endocrinology jointly with the Russian Academy of postgraduate education. It is intended for endocrinologists and allied professions: physicians,pediatricians, family physicians and health care providers. The journal is published summarizing the experience of leading foreign and domestic practitioners, clinical guidelines, test questions and contemporary treatment algorithms, as well as announcements of scientific events.
The purpose of the journal is to bring to the medical community the latest information about the latest advances in etiopathogenesis and therapy of endocrine diseases, to highlight the latest research results and to improve the quality of postgraduate education and medical care to the population. This edition is a kind of textbook for a wide audience of medical specialists in the framework of continuous medical education.
The first issue of the magazine dedicated to diabetes - one of the leading causes of death of people worldwide. Today in Russia is registered more than 3 million patients with diabetes, 93% of patients with diabetes mellitus type 2 (however, according to epidemiological studies such patients is 3-4 times more).
And the incidence continues to grow. By 2025 the number of diabetes patients will grow to 435 million people.
Scientists and diabetologists all over the world for many decades engaged in the search for the optimal methods of therapy of diabetes. So, for the last 10 years much has been done for successful diagnosis, prevention and treatment of diabetes: modern technologies for monitoring the level of blood sugar, continuous subcutaneous injection of insulin, developed and implemented new analogues of insulin. Today, a fundamentally new approach in the treatment of diabetes mellitus type 2 recognized line drugs incretin series. And if you perform all the advances in the treatment of diabetes, it is safe to say that the discovery of new drugs class glucagonoma peptide 1 (GLP 1) is a major breakthrough in the field of innovative technologies, which importance is comparable with the creation of insulin analogs.
It is proved that effective control of diabetes can minimize or prevent the development of many related complications. In this case, along with drug supply is the most important role in the management of diabetes, playing a team consisting of highly professional medical staff (doctor, nurse, specialist, therapy, psychologist) and patient, well informed and motivated to achieve your goals.
For more details on the topic of diabetes is revealed next, in the pages of this number.
We invite You to join our readers and we hope that the materials published in the magazine will not only be useful and relevant for medical professionals, but will make it a desktop teaching aid the practitioner.